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According to theBylaws of theAmericanAssociation
of Colleges of Pharmacy (AACP), the Research and Grad-
uate Affairs Committee (RGAC) shall provide assistance
to the Association in developing its research, graduate ed-
ucation, and scholarship agenda. This assistance may in-
clude facilitating colleges and schools in formulating and
advancing legislative and regulatory initiatives, and nur-
turing collaborative activities with organizations sharing
an interest in issues related to the pharmaceutical sciences.
Following the retirement of Dr. Kenneth Miller, for-
merly Senior Vice President at AACP in June 2010,
AACP made a strategic decision approved by the Board
of Directors to hire a Vice President of Research and
Graduate Education serving as a Chief Science Officer
(CSO), who deeply understands contemporary research
and anticipated scientific progress that will benefit AACP
and its members. AACP seeks to deepen its relationships
with all public and private funding agencies supporting
the spectrum of the pharmaceutical sciences and the CSO
will have greater capacity for the primary areas of respon-
sibility in research and scientific affairs.Yuen-Sum(Vincent)
Lau, Ph.D., previously the John & Rebecca Moores Pro-
fessor and Chair of Pharmacological and Pharmaceutical
Sciences Department at University of Houston College of
Pharmacy, assumed this new role in July, 2011.
During the first transitional year, the new CSO was
responsible to evaluate the existing AACP programs and
make necessary improvements. In addition, President
Brian Crabtree had charged AACP to create a Special Ad-
visory Committee on Research and Graduate Education
to advise and provide assistance to the new CSO in
strengthening research, graduate education, and scholar-
ship for the academy. The recommended strategic direc-
tions included building relationships and collaboration
with scientific organizations and funding agencies, lead-
ing scientists in and out of pharmacy education, creating
an Academic Research Fellows Program, and strengthen-
ing and supporting graduate education.
The Special Advisory Committee on Research and
Graduate Educationmet onDec. 13-14, 2011 inAlexandria
Virginia, during which the 2010-11 Research and Graduate
Affairs Committee Report1 and the currentAACPStrategic
Plan Critical Issue 5 on “Research and Scholarship” were
examined and discussed. Throughout the year, the CSO
contacted the committee members via electronic commu-
nication. The Committee met again through a conference
call on June 26, 2012 to review the progress and discuss
future agenda. This report summarizes the Committee’s
discussion and AACP’s execution on tasks related to re-
search and graduate affairs within the year.
NEW INVESTIGATOR AWARD PROGRAM
AACP has annually administered the New Investi-
gators Program for Pharmacy Faculty since 1986 with the
financial support of the American Foundation for Phar-
maceutical Education. This source of financial support
ceased after 2008. Because this program is so vital to
pharmacy faculty in their early stage especially allowing
them to develop novel and independent research ideas and
projects, and such resources can assist them to generate
critical preliminary data so they can be competitive in
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applying for other extramural research support, AACP
and the Board of Directors approved to resume this pro-
gram in 2010 entirely supported by the AACP funds. In
2011, the Board further approved to increase the number
of awards from 15 to 18 and it is now named as the AACP
New Investigator Award (NIA).
In 2011, the application and review process had been
revised. Briefly, the CSO offered a webinar to potential
applicants on how to prepare and submit an NIA research
proposal. The applicantswere urged to identify amentor for
reviewing and providing guidance to their research project.
The CSO also conducted several conference calls with the
AACP academic section leaders to discuss about how to
form application review panels and how to score applica-
tions based on scientific merit. At the end, all Section Past-
Chairs were involved in the decision of selecting awardees
according to the significance, quality, innovation, and ap-
proach of the proposals, and successful potential of the
applicants. The aggregated information on the 2011 NIA
is shown inTable 1.As a post-awardmeasure, theCSOwill
begin to track their research progress by requiring awardees
to submit a 6-month progress report and an end-of-year
financial and scientific report. The awardees will also be
provided a travel stipend and required to present their find-
ings at the next annual meeting after the completion of the
funded research projects. To better prepare the future new
investigators, the CSO offered a pre-session on “Research
Proposal Preparation Workshop for New Faulty Investiga-
tors” at the 2012 AACP Annual Meeting in Kissimmee,
FL., which covered research application strategies for
a wide range of pharmacy-related areas.
FACULTY MENTORING/COLLABORATIVE
PROGRAMS FOR RESEARCH AND
SCHOLARSHIP
Faculty mentoring has been a continuous topic of
discussion within the academy in past and present years.
Programming for faculty leadership and mentorship is an
AACP Strategic Plan Goal (Critical Issue 1 on improving
faculty recruitment, retention and productivity). Faculty
mentoring is also recognized as a top priority according
to the recent membership needs analysis. Following the
AACP Leadership Retreat in Chicago in March 2012,
Chair-elects of Council of Deans, Council of Faculty,
and Council of Sections gathered and agreed to create
a joint taskforce to conduct an in-depth investigation
and provide recommendations on how to enhance phar-
macy faculty mentoring. The AACP staff liaisons for the
three Councils met and developed a framework for the
Tri-Council Chair-elects to consider before developing
the charges for the taskforce. The outlined framework
for a comprehensive and effective Pharmacy Faculty
Mentoring Plan was not intended to create a desirable
fit-for-all mentoring program, instead it was designed to
examine and bring forth a multidisciplinary mentoring
structurewith existing resources. The taskforcewas asked
to determine what considers a good and effective mentor-
mentee relationship, what should be the desirable quali-
fications of a mentor, what are the responsibilities of
mentors and mentees, what are the resources that are al-
ready available or should be developed for fulfilling the
needs of mentees, and what mentoring pieces should be
offered by the university, professional organization, or
can be delivered by the modern technology. More impor-
tantly, the mentoring plan should be applicable to faculty
of all disciplines and at all ranks, not just the new faculty.
It is expected that this taskforce work will be completed
by summer 2013.
ANNUAL PHARMACY FACULTY
RESEARCH GRANT DATA REPORT
Since 1995, AACP has annually collected and pub-
lished an aggregated report on Pharmacy Faculty Re-
search Grant Data (PFRGD) for each college or school








Biological Sciences 52 4 43 4
Chemistry 19 1 15 3
Continuing Professional Education 1 0 1 0
Experiential Education 1 0 0 0
Libraries/Educational Resources 2 1 0 0
Pharmaceutics 36 0 29 3
Pharmacy Practice 40 0 20 4
Social and Administrative Sciences 29 1 22 4
Totalb 180 7 130 18
a One ranked application withdrew due to subsequent receipt of another foundation grant.
b Grant total amount awarded: $172,146 (individual awards range from $7,170-$10,000).
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of pharmacy. The published PFRGD reports in earlier
years contained primarily the NIH R01 Principal Investi-
gator (PI) grants. Since 2002, reporting on other types of
federal and non-federal awards was expanded. However,
besides the NIH grants, the verification of other types of
grants submitted by colleges and schools had been quite
challenging. Up till 2010, a total of 11 layouts had been
generated each year showing different ways that the grant
data were presented in rank order.
This year, as part of AACP’s continual efforts to
enhance member service and improve processes, we ex-
tensively reexamined the purpose,methodology, validity,
interpretation and use of faculty research grant data. As
a result of that study,we decided to change the data report-
ing process this year. We implemented a modified system
for reporting extramural faculty PI-initiated, peer-reviewed
research grants that have specific research aims and a scope
of work including grants from non-federal agencies.
Through our lengthy verification process, we focused
on data accuracy. The data collection and validation pro-
cess is fully described in the report.
Guiding our work was our belief that AACP should
refrain from officially ranking colleges/schools using
a single parameter based on the National Institutes of
Health (NIH) funding level and should refrain from pro-
viding different layouts for colleges and schools to make
preferential data interpretations. Instead, we provided
validated and accurate data for colleges/schools to use
as each desires. In the 2011 report, to maintain full trans-
parency, the process and methodology for generating this
report were fully disclosed. The report contained not only
NIH grants, but also other federal, non-federal, and col-
laborative research grants and subcontracts. The PFRGD
will be available online to provide more interactive func-
tionalities allowing colleges/schools to generate their
own reports using their selected parameters for bench-
marking purpose.
AACP is pleased to announce, in the 2011 our col-
leges and schools collectively received $288.4 million
NIH PI grants and $415.2 million total research grants
(including the NIH, other federal, non-federal, and col-
laborative research subcontracts). The Committee be-
lieved that NIH grants are most useful data to most
schools that should be kept separate from other federal
grants. Total extramural funding is also important to in-
dicate how much research is conducted at colleges and
schools. However, some of the indicators/denominators
(e.g. number of FTE, Ph.D., etc.) used in the past years are
quite variable from school to school and are not meaning-
ful. On the other hand, the number of funded PI faculty,
who are responsible for generating the grants would be
useful and is now added.
RESEARCH ADVOCACY AND OUTREACH
The AACP Strategic Critical Issue 5 calls for the
CSO to reach out to colleges/schools for the purpose of
learning about organizational, financial and operational
issues affecting research and graduate education at our
member institutions, listening to members and nonmem-
bers to discern their needs for programs and services, and
to have opportunities to share up-to-date information
about AACP with faculty and administrators.
Since joining AACP, the CSO had visited 15 col-
leges and schools, which included University of Texas
in Austin (July 6, 2011), University of Washington in
Seattle (September 8), University of British Columbia
in Vancouver (September 9), University of Kentucky
(October 13-14), University of Minnesota (October 27-
28), Duquesne University (November 14), University of
Pittsburgh (November 15-16), UC-San Diego (February
15-16, 2012), University of Southern California (Febru-
ary 17), University of North Carolina (February 28-29),
Northeastern University (March 13-14), Massachusetts
Colleges of Pharmacy (March 16), Albany College of
Pharmacy (April 11-13), and University of Maryland
(April 16). The CSO attended the American Association
of Pharmaceutical Scientists meeting (Oct. 24-25, 2011)
reaching out to basic pharmaceutical scientists and grad-
uate students, who do not routinely attend the AACP
annual meeting. The CSO also attended the Pharmacy
Deans Research Group meeting in Tucson, AZ and met
with a few faculty at the University of Arizona campus
(January 13-14, 2012).
The AACP Science Office and Advocacy Office
have jointly assembled relevant faculty research expert
panels to examine directions, methodology, and policies
surrounding pharmacy and pharmaceutical research at
the request of funding agencies. For example, a Patient-
Centered Outcomes Research Institute (PCORI) panel was
formed and chaired by Dr. Diana Brixner of University of
Utah College of Pharmacy, which reviewed and provided
insightful comments for the revision of PCORI’s Transla-
tionTableFramework.The similar approach for advocating
pharmacy and pharmaceutical research will be continued
by experts in the academy. It was also suggested by the
Committee forAACP to establish relationshipwith funding
agencies and nominate more scientists to serve on councils
and review panels within funding agencies.
PROPOSED ACADEMIC RESEARCH
FELLOWS PROGRAM
Following the recommendation of the 2010-11 Re-
search and Graduate Affairs Committee1, AACP has con-
sidered the design of a new Academic Research Fellows
Program (ARFP) modeled upon the successful Academic
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Leadership Fellows Program, which is currently in its 9th
year. The ARFP was envisioned to accelerate the careers
of promising pharmaceutical scientists as collaborative
research leaders. The structure and feasibility of the pro-
posed ARFP were further discussed this year.
Previously it was thought that ARFP should be
designed to advance the research of individual faculty
at mid-career level and bring new dimensions to their
research and professional development. The CSO and
this Committee recognized that organizing an ARFP for
individuals from diverse backgrounds and disciplines
would be difficult to manage. AACP should not replicate
some programs that offer research proposal writingwork-
shops that would require a lot of personalized effort and
cost-associated resources to train or retrain a faculty one-
on-one from an organization stand-point. The Committee
believed that mentoring individual faculty in research and
scholarship could be best handled at college/school level.
However, the academy needs more better-trained men-
tors, who understand the whole research enterprise and
who can help to build research teams and programs at
home institutions. Therefore, the ARFP should be de-
signed to train researchers not only to advance their own
research programs, but also for them to mentor their col-
leagues at all ranks and disciplines.
The ARFP is currently at its development stage aim-
ing for an inaugural class in 2013. The main expected
outcomes of the Fellows Program will include getting
to know and making relationship with major funding
agencies, learning the process for developing and manag-
ing a successful research program, achieving effective-
ness in research advocacy, establishing a contemporary
graduate program that will offer a multidisciplinary cur-
riculum, and identifying training grants and individual
fellowships for graduate students. Potential trainers and
facilitators for the Fellows Program will be research
leaders from academia, NIH and other federal agencies,
foundations and associations, and industrial entities.
GRADUATE PROGRAMS AND STUDENT
RECRUITMENT
The Committee recognized that AACP needs to ex-
amine and develop products for better marketing phar-
macy and pharmaceutical graduate degree programs and
for helping schools to recruit quality graduate students,
especially among the US graduates. Colleges and schools
that offer graduate degrees should make sure that their
programs are rigorous and their graduates are well trained
and prepared for the future biomedical workforce. We
should also encourage more research scientists to con-
sider academic pharmacy jobs and assist them to become
excellent and competitive research investigators. AACP
had now linked its Web site listing graduate degree pro-
grams in North America to individual school’s Web page
that will allow potential applicants easy access to the de-
gree programs offered by colleges and schools of phar-
macy. AACP staff is also exploring the possibility of
listing the graduate degree programs within the web-
based PharmCas portal, which currently only contains
college/school pages for the centralized PharmD degree
application and admission. The CSO has worked with the
American Association of Pharmaceutical Scientists and
the AACP Graduate Education SIG on how to enhance
graduate education and programs, to identify more re-
sources for supporting graduate students, dual-degree stu-
dents, and to stimulate their interest in research. Further
investigation and discussion on developing and imple-
menting a good business model for graduate and post-
graduate programs concerning the quality of teaching/
research assistants, residents, postdoctoral fellows, and
faculty is also warranted.
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